Blog
RSS FeedPosted by Michael Wonder on 12 Sep 2017
War on drugs: big pharma fights NHS bill curbs
10 September 2017 - With NHS budgets under pressure and medicine prices inexorably going up, something had to give. ...
Posted by Michael Wonder on 11 Sep 2017
A much needed corrective on drug development costs
11 September 2017 - Contemporary pharmaceutical industry pricing practices are threatening to undermine the health care industry’s and policymakers’ efforts at ...
Posted by Michael Wonder on 11 Sep 2017
Research and development spending to bring a single cancer drug to market and revenues after approval
11 September 2017 - Prasad & Mailankody have estimated research and development spending for developing a new cancer drug. ...
Posted by Michael Wonder on 11 Sep 2017
Medical technology investment to improve lives
11 September 2017 - The Australian Government will fund three medical breakthroughs to help people with severe disabilities walk again ...
Posted by Michael Wonder on 07 Sep 2017
Drug makers push back on data requirements in Australia’s provisional approval pathway
5 September 2017 - A who’s who of leading drug makers have raised concerns about the proposed data requirements for ...
Posted by Michael Wonder on 28 Aug 2017
NSW Minister for Health Brad Hazzard says more competition needed in medical device sector
27 August 2017 - The NSW Minister for Health, Brad Hazzard, says the prices of surgically implanted devices like artificial ...
Posted by Michael Wonder on 28 Aug 2017
Statement on Government’s response to Productivity Commission’s inquiry in intellectual property
25 August 2017 - Medicines Australia notes the Government has today released their response to the Productivity Commission’s Inquiry in ...
Posted by Michael Wonder on 09 Aug 2017
Drug makers' hopes for gene therapy rise despite tiny sales in Europe
8 August 2017 - The science of gene therapy is finally delivering on its potential, and drug makers are now ...
Posted by Michael Wonder on 03 Aug 2017
A rush for immunotherapy cancer drugs means new bedfellows
3 August 2017 - Fierce rivals in pharma are co-operating. ...
Posted by Michael Wonder on 03 Aug 2017
Addressing antimicrobial resistance and stewardship: the Priority Antimicrobial Value and Entry (PAVE) award
3 August 2017 - Antimicrobial-resistant infections affect more than 2 million people annually in the United States alone, accounting for an ...
Posted by Michael Wonder on 01 Aug 2017
EMA encourages tailored development of medicines for older people
1 August 2017 - EMA invites comments on reflection paper by 31 January 2018. ...
Posted by Michael Wonder on 29 Jul 2017
Concept paper on development and lifecycle of personalised medicines and companion diagnostic
28 July 2017 - Public consultation to end on 31 October 2017. ...
Posted by Michael Wonder on 29 Jul 2017
Pharmaceutical companies’ policies on access to trial data, results, and methods: audit study
26 July 2017 - Goldacre et al. set out to identify the policies of major pharmaceutical companies on transparency of trials, ...
Posted by Michael Wonder on 29 Jul 2017
Surrogate endpoints in oncology: when are they acceptable for regulatory and clinical decisions, and are they currently overused?
26 July 2017 - Surrogate outcomes are not intrinsically beneficial to patients, but are designed to be easier and faster to ...
Posted by Michael Wonder on 24 Jul 2017
Companies rush to develop ‘utterly transformative’ gene therapies
23 July 2017 - The approval of gene therapy for leukaemia, expected in the next few months, will open the ...